Ausgabe 4/2020
Inhalt (19 Artikel)
Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy
M. Protopapa, V. Kouloulias, A. Kougioumtzopoulou, Z. Liakouli, C. Papadimitriou, A. Zygogianni
Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients
J. Feliu, V. Heredia-Soto, R. Gironés, B. Jiménez-Munarriz, J. Saldaña, C. Guillén-Ponce, M. J. Molina-Garrido
Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis
X. Wang, L. Chen, Y. Sun, B. Zhang
Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis
N. Wu, F. Fu, L. Chen, Y. Lin, P. Yang, C. Wang
The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo
N. Dana, S. Haghjooy Javanmard, G. Vaseghi
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial
G. Quintero Aldana, M. Salgado, S. Candamio, J. C. Méndez, M. Jorge, M. Reboredo, L. Vázquez Tuñas, C. Romero, M. Covela, A. Fernández Montes, M. Carmona, Y. Vidal Insua, R. López
Human colorectal cancer derived-MSCs promote tumor cells escape from senescence via P53/P21 pathway
G. Li, R. Zhang, X. Zhang, S. Shao, F. Hu, Y. Feng
Resection of liver metastases from breast cancer: a multicentre analysis
X. He, Q. Zhang, Y. Feng, Z. Li, Q. Pan, Y. Zhao, W. Zhu, N. Zhang, J. Zhou, L. Wang, M. Wang, Z. Liu, H. Zhu, Z. Shao, L. Wang
Stromal fibroblast-derived MFAP5 promotes the invasion and migration of breast cancer cells via Notch1/slug signaling
Z. Chen, X. Yan, K. Li, Y. Ling, H. Kang
Red and processed meat consumption and esophageal cancer risk: a systematic review and meta-analysis
Z. Zhao, F. Wang, D. Chen, C. Zhang
Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification
J. Cornillie, A. Wozniak, H. Li, Y. K. Gebreyohannes, J. Wellens, D. Hompes, M. Debiec-Rychter, R. Sciot, P. Schöffski
Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients
B. Fox, M. de Toro Carmena, R. Álvarez Álvarez, A. Calles Blanco, C. López López, S. Pérez Ramírez, J. Á. Arranz, M. Martín, I. Márquez-Rodas
ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling
X. Xuan, J. Zhou, Z. Tian, Y. Lin, J. Song, Z. Ruan, B. Ni, H. Zhao, W. Yang
The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients
K. Chen, J. Quan, J. Yang, Z. Chen
Breast cancer and cytomegalovirus
A. K. Richardson, L. C. Walker, B. Cox, H. Rollag, B. A. Robinson, H. Morrin, J. F. Pearson, J. D. Potter, M. Paterson, H.-M. Surcel, E. Pukkala, M. J. Currie
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
A. Passaro, P. Mancuso, S. Gandini, G. Spitaleri, V. Labanca, E. Guerini-Rocco, M. Barberis, C. Catania, E. Del Signore, F. de Marinis, F. Bertolini
Outpatient management of incidental pulmonary embolism in cancer patient
Andrés J. Muñoz Martín, Magdalena Carmen Ruiz Zamorano, María Carmen Viñuela Benéitez, Laura Ortega Morán, Ángela García Pérez, Miguel Martín Jiménez
Bemiparin as a long-term treatment for venous thrombosis in cancer patients: the ELEBAMA study
E. Pina, M. Antonio, J. Peris, E. Rosselló, P. Domènech, J. Peñafiel, C. Tebe
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
A. Passaro, P. Mancuso, S. Gandini, G. Spitaleri, V. Labanca, E. Guerini-Rocco, M. Barberis, C. Catania, E. Del Signore, F. de Marinis, F. Bertolini